Parabolic Drugs Ltd

The CBI has booked top executives of Chandigarh-based Parabolic Drugs Ltd for allegedly defrauding a consortium led by Central Bank of India of Rs 1626.74 crore, officials said Friday.

Parabolic Drugs Ltd has informed BSE regarding a Press Release titeld "Q1FY12 Performance".

Parabolic Drugs Ltd  has informed BSE that a meeting of the Board of Directors of the Company will be held on August 13, 2011, inter alia, to consider the following: 1. To consider and take on record audited financial results of the Company for the financial year ended March 31, 2011. 2. To consider and take on record the unaudited financial r...

With reference to the earlier announcement dated August 05, 2011 regarding the meeting of the Board of Directors of the Company scheduled to be held on August 13, 2011, Parabolic Drugs Ltd has now informed BSE that in the said meeting, the Board will also discuss the issuance of Convertible Warrants on preferential basis to various investors.

Parabolic Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 08, 2010 :  1. Approved the Resignation of Dr. Deepali Gupta from the directorship of the Company w.e.f. November 08, 2010.  2. Approved the Appointments of Mr. Gurpreet Singh Sandhu and Mr. Nikhil Goel as the Additional Directo...

Parabolic Drugs Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on September 28, 2010, inter alia, have accorded to the following:  1. The Audited Balance Sheet as at March 31, 2010, Profit & Loss Account for the year ended on that date together with Report of Auditor's and Directors thereo...

The board at its meeting held on October 29, 2011 has approved for the same

The board at its meeting held on October 29, 2011 has approved for the same

The CBI has booked top executives of Chandigarh-based Parabolic Drugs Ltd for allegedly defrauding a consortium led by Central Bank of India of Rs 1626.74 crore, officials said Friday.

Parabolic Drugs Ltd has informed BSE regarding a Press Release titeld "Q1FY12 Performance".

Parabolic Drugs Ltd  has informed BSE that a meeting of the Board of Directors of the Company will be held on August 13, 2011, inter alia, to consider the following: 1. To consider and take on record audited financial results of the Company for the financial year ended March 31, 2011. 2. To consider and take on record the unaudited financial r...

With reference to the earlier announcement dated August 05, 2011 regarding the meeting of the Board of Directors of the Company scheduled to be held on August 13, 2011, Parabolic Drugs Ltd has now informed BSE that in the said meeting, the Board will also discuss the issuance of Convertible Warrants on preferential basis to various investors.

Parabolic Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 08, 2010 :  1. Approved the Resignation of Dr. Deepali Gupta from the directorship of the Company w.e.f. November 08, 2010.  2. Approved the Appointments of Mr. Gurpreet Singh Sandhu and Mr. Nikhil Goel as the Additional Directo...

Parabolic Drugs Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on September 28, 2010, inter alia, have accorded to the following:  1. The Audited Balance Sheet as at March 31, 2010, Profit & Loss Account for the year ended on that date together with Report of Auditor's and Directors thereo...

The board at its meeting held on October 29, 2011 has approved for the same

The board at its meeting held on October 29, 2011 has approved for the same